HSP90B1 and neoplasm: DFS analysis (Figure 2b) indicated that the high expression of HSP90B1 was associated with poor prognosis of ACC (p = 0.0022), BLCA (p = 0.041), CHOL (p = 0.021), KIRC (p = 0.02), KIRP (p = 0.0054), LUAD (p = 0.038), LUSC (p = 0.047), and UVM (p = 0.024) tumours.